Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression

Breast Cancer Research

Volumn 13, Issue 4, 2011, Pages

  Connolly, Diana ^a   Yang, Zhixia ^a   Castaldi, Maria ^b   Simmons, Nichelle ^b   Oktay, Maja H ^a   Coniglio, Salvatore ^a   Fazzari, Melissa J ^a   Verdier Pinard, Pascal ^c,d,e   Montagna, Cristina ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JACOBI MEDICAL CENTER   (United States)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Breast cancer; Cytoskeleton; Epigenetics; Oncogene; Septin 9

Indexed keywords

MESSENGER RNA; SEPTIN; SEPTIN 9; UNCLASSIFIED DRUG; ISOPROTEIN; SEPT9 PROTEIN, HUMAN; SEPTIN 9, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; ADENOCARCINOMA; ALTERNATIVE RNA SPLICING; ANIMAL; BREAST TUMOR; C57BL MOUSE; CELL MOTION; CELL NUCLEUS; CYTOLOGY; CYTOPLASM; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; PROMOTER REGION; REFERENCE VALUE; TUMOR CELL LINE; UDDER;

ADENOCARCINOMA; ALTERNATIVE SPLICING; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CYTOPLASM; DNA METHYLATION; EPIGENESIS, GENETIC; EPITHELIAL CELLS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; REFERENCE VALUES; SEPTINS;

EID: 80255132864     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2924     Document Type: Article

References (51)

1. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007, 1773:642-652. 10.1016/j.bbamcr.2006.07.001, 16926057.
2. Spiliotis ET, Nelson WJ. Here come the septins: novel polymers that coordinate intracellular functions and organization. J Cell Sci 2006, 119:4-10. 10.1242/jcs.02746, 16371649.
3. Montagna C, Lyu MS, Hunter K, Lukes L, Lowther W, Reppert T, Hissong B, Weaver Z, Ried T. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003, 63:2179-2187.
4. Kuttler F, Mai S. Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis. Semin Cancer Biol 2007, 17:56-64. 10.1016/j.semcancer.2006.10.007, 17116402.
5. Sørensen AB, Lund AH, Ethelberg S, Copeland NG, Jenkins NA, Pedersen FS. Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J Virol 2000, 74:2161-2168. 10.1128/JVI.74.5.2161-2168.2000, 111696, 10666245.
6. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, Jenkins NA, Copeland NG. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002, 32:166-174. 10.1038/ng949, 12185365.
7. Osaka M, Rowley JD, Zeleznik-Le NJ. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci USA 1999, 96:6428-6433. 10.1073/pnas.96.11.6428, 26898, 10339604.
8. Taki T, Ohnishi H, Shinohara K, Sako M, Bessho F, Yanagisawa M, Hayashi Y. AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). Cancer Res 1999, 59:4261-4265.
9. Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, Price J, Godwin AK, Johnston PG, Russell SE. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol 2003, 201:581-588. 10.1002/path.1484, 14648661.
10. Scott M, McCluggage WG, Hillan KJ, Hall PA, Russell SE. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int J Cancer 2006, 118:1325-1329. 10.1002/ijc.21486, 16161048.
11. Hall PA, Jung K, Hillan KJ, Russell SE. Expression profiling the human septin gene family. J Pathol 2005, 206:269-278. 10.1002/path.1789, 15915442.
12. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G, Plinkert P, Herpel E, Smiraglia D, Plass C. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 2008, 68:4494-4499. 10.1158/0008-5472.CAN-07-6509, 18559491.
13. Stanbery L, D'Silva NJ, Lee JS, Bradford CR, Carey TE, Prince ME, Wolf GT, Worden FP, Cordell KG, Petty EM. High SEPT9_v1 expression is associated with poor clinical outcomes in head and neck squamous cell carcinoma. Transl Oncol 2010, 3:239-245. 2915415, 20689765.
14. Amir S, Golan M, Mabjeesh NJ. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway. Mol Cancer Res 2010, 8:643-652. 10.1158/1541-7786.MCR-09-0497, 20407014.
15. Amir S, Wang R, Matzkin H, Simons JW, Mabjeesh NJ. MSF-A interacts with hypoxia-inducible factor-1α and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 2006, 66:856-866. 10.1158/0008-5472.CAN-05-2738, 16424018.
16. Nagata K, Kawajiri A, Matsui S, Takagishi M, Shiromizu T, Saitoh N, Izawa I, Kiyono T, Itoh TJ, Hotani H, Inagaki M. Filament formation of MSF-A, a mammalian septin, in human mammary epithelial cells depends on interactions with microtubules. J Biol Chem 2003, 278:18538-18543. 10.1074/jbc.M205246200, 12626509.
17. Estey MP, Di Ciano-Oliveira C, Froese CD, Bejide MT, Trimble WS. Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission. J Cell Biol 2010, 191:741-749. 10.1083/jcb.201006031, 2983063, 21059847.
18. Grützmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F, Roblick UJ, Bruch HP, Koch R, Liebenberg V, Devos T, Song X, Day RH, Sledziewski AZ, Lofton-Day C. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008, 3:e3759. 10.1371/journal.pone.0003759, 2582436, 19018278.
19. McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Johnston PG, Russell SE. Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene 2001, 20:5930-5939. 10.1038/sj.onc.1204752, 11593400.
20. Robertson C, Church SW, Nagar HA, Price J, Hall PA, Russell SE. Properties of SEPT9 isoforms and the requirement for GTP binding. J Pathol 2004, 203:519-527. 10.1002/path.1551, 15095474.
21. Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM, Petty EM. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res 2007, 67:8554-8564. 10.1158/0008-5472.CAN-07-1474, 17875694.
22. Downing TE, Oktay MH, Fazzari MJ, Montagna C. Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer. Cancer Genet Cytogenet 2010, 198:52-61. 10.1016/j.cancergencyto.2009.12.007, 20303015.
23. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003, 163:2113-2126. 10.1016/S0002-9440(10)63568-7, 1892434, 14578209.
24. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527. 10.1016/j.ccr.2006.10.008, 2730521, 17157791.
25. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009, 4:e6146. 10.1371/journal.pone.0006146, 2702084, 19582160.
26. Kondo Y, Shen L, Issa JP. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 2003, 23:206-215. 10.1128/MCB.23.1.206-215.2003, 140684, 12482974.
27. He Q, Chen HY, Bai EQ, Luo YX, Fu RJ, He YS, Jiang J, Wang HQ. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet 2010, 202:1-10. 10.1016/j.cancergencyto.2010.05.018, 20804913.
28. Roohi J, Cammer M, Montagna C, Hatchwell E. An improved method for generating BAC DNA suitable for FISH. Cytogenet Genome Res 2008, 121:7-9. 10.1159/000124374, 18544919.
29. Bates D, Chambers J, Dalgaard P, Falcon S, Gentleman R, Hornik K, Iacus S, Ihaka R, Leisch F, Ligges U, Lumley T, Maechler M, Murdoch D, Murrell P, Plummer M, Ripley B, Sarkar D, Temple Lang D, Tierney L, Urbanek S. R: A Language and Environment for Statistical Computing. Version 2.8. 2008, Vienna: The R Project for Statistical Computing., http://www.r-project.org/
30. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
31. Nagata K, Asano T, Nozawa Y, Inagaki M. Biochemical and cell biological analyses of a mammalian septin complex, Sept7/9b/11. J Biol Chem 2004, 279:55895-55904. 10.1074/jbc.M406153200, 15485874.
32. Pizarro-Cerdá J, Jonquières R, Gouin E, Vandekerckhove J, Garin J, Cossart P. Distinct protein patterns associated with Listeria monocytogenes InlA- or InlB-phagosomes. Cell Microbiol 2002, 4:101-115. 10.1046/j.1462-5822.2002.00169.x, 11896766.
33. Tachibana T, Okazaki E, Yoshimi T, Azuma M, Kakehashi A, Wanibuchi H. Rat monoclonal antibody specific for septin 9. Hybridoma (Larchmt) 2010, 29:169-171.
34. ImageJ software. , http://rsb.info.nih.gov/ij/
35. ENCODE Project Consortium The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004, 306:636-640. ENCODE Project Consortium.
36. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431. 10.1093/bioinformatics/18.11.1427, 12424112.
37. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005, 102:15785-15790. 10.1073/pnas.0507816102, 1276092, 16243968.
38. Thompson RF, Suzuki M, Lau KW, Greally JM. A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry. Bioinformatics 2009, 25:2164-2170. 10.1093/bioinformatics/btp382, 2800352, 19561019.
39. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979, 6:65-70.
40. Burdall SE, Hanby AM, Lansdown MR, Speirs V. Breast cancer cell lines: friend or foe?. Breast Cancer Res 2003, 5:89-95. 10.1186/bcr577, 154155, 12631387.
41. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992, 12:954-961. 369527, 1312220.
42. Kinoshita M, Field CM, Coughlin ML, Straight AF, Mitchison TJ. Self- and actin-templated assembly of mammalian septins. Dev Cell 2002, 3:791-802. 10.1016/S1534-5807(02)00366-0, 12479805.
43. Hall PA, Todd CB, Hyland PL, McDade SS, Grabsch H, Dattani M, Hillan KJ, Russell SE. The septin-binding protein anillin is overexpressed in diverse human tumors. Clin Cancer Res 2005, 11:6780-6786. 10.1158/1078-0432.CCR-05-0997, 16203764.
44. Makhnevych T, Ptak C, Lusk CP, Aitchison JD, Wozniak RW. The role of karyopherins in the regulated sumoylation of septins. J Cell Biol 2007, 177:39-49. 10.1083/jcb.200608066, 2064105, 17403926.
45. Kremer BE, Adang LA, Macara IG. Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell 2007, 130:837-850. 10.1016/j.cell.2007.06.053, 2085444, 17803907.
46. deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C, Habermann JK, Fleshner PR, Oubre BM, Day R, Sledziewski AZ, Lofton-Day C. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009, 55:1337-1346. 10.1373/clinchem.2008.115808, 19406918.
47. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, Turecki G, Delaney A, Varhol R, Thiessen N, Shchors K, Heine VM, Rowitch DH, Xing X, Fiore C, Schillebeeckx M, Jones SJ, Haussler D, Marra MA, Hirst M, Wang T, Costello JF. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010, 466:253-257. 10.1038/nature09165, 20613842.
48. McDade SS, Hall PA, Russell SE. Translational control of SEPT9 isoforms is perturbed in disease. Hum Mol Genet 2007, 16:742-752. 10.1093/hmg/ddm003, 17468182.
49. Gonzalez ME, Makarova O, Peterson EA, Privette LM, Petty EM. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells. Cell Signal 2009, 21:477-487. 10.1016/j.cellsig.2008.11.007, 2811713, 19071215.
50. Surka MC, Tsang CW, Trimble WS. The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis. Mol Biol Cell 2002, 13:3532-3545. 10.1091/mbc.E02-01-0042, 129964, 12388755.
51. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 2010, 70:3780-3790. 10.1158/0008-5472.CAN-09-4439, 20388789.